"إعلانات"
"------------------------------------------------"
Blood Pressure Guidelines Are Far Too High 9-11-2015 American Heart Association annual meeting
A large study shows that more people could benefit from blood pressure levels that are much lower than currently recommended
Scientists at the American Heart Association annual meeting Monday presented surprising results from a much-anticipated trial that call into question current blood pressure recommendations. The SPRINT trial—short for systolic blood pressure intervention trial—is the largest study yet to compare people who kept their blood pressure at currently recommended levels of 140/90 to people who dropped their measurements to below 120/80.
The result? The lower the blood pressure, the better the outcome. Those who hit the systolic blood pressure target of 120 had significantly lower rates of premature heart-related deaths and early deaths from any cause. The difference was dramatic enough for the investigators to halt the trial nearly two years early.
“The general message here seems to be that lower seems be better,” says Dr. Paul Whelton, from Tulane University and chair of the SPRINT trial. “Overall we deem that the benefits of the lower blood pressure far outweigh the potential for risk.”
Blood Pressure Guidelines Are Far Too High 9-11-2015 American Heart Association annual meeting
A large study shows that more people could benefit from blood pressure levels that are much lower than currently recommended
Scientists at the American Heart Association annual meeting Monday presented surprising results from a much-anticipated trial that call into question current blood pressure recommendations. The SPRINT trial—short for systolic blood pressure intervention trial—is the largest study yet to compare people who kept their blood pressure at currently recommended levels of 140/90 to people who dropped their measurements to below 120/80.
The result? The lower the blood pressure, the better the outcome. Those who hit the systolic blood pressure target of 120 had significantly lower rates of premature heart-related deaths and early deaths from any cause. The difference was dramatic enough for the investigators to halt the trial nearly two years early.
“The general message here seems to be that lower seems be better,” says Dr. Paul Whelton, from Tulane University and chair of the SPRINT trial. “Overall we deem that the benefits of the lower blood pressure far outweigh the potential for risk.”